Portfolio
34
companies
52North
52North develops diagnostic tools and digital platforms to transform urgent care pathways in oncology.
BKwai
BKwai delivers a data platform that helps engineers monitor built infrastructure.
Barocal
Barocal develops solid-state materials for eco-friendly heating and cooling.
Bond180
Bond180 provides technology solutions for primary fixed income markets.
Cambridge GaN Devices
Developer of power semiconductor devices using Gallium-Nitride on Silicon technology.
Cambridge Photon Technology
Cambridge Photon Technology develops drop-in materials to increase solar panel power output.
Carbon Re
Carbon Re builds artificial intelligence to decarbonise energy-intensive industries.
CardiaTec Biosciences
CardiaTec Biosciences applies artificial intelligence to multiomic data for cardiovascular drug discovery.
DefiniGEN
DefiniGEN creates human cell models to support drug discovery and preclinical research.
Echion Technologies
Echion Technologies develops niobium anode materials for lithium-ion batteries.
Flusso
Flusso develops miniaturised flow sensors for consumer and industrial applications.
HexagonFab
HexagonFab builds analytical lab instruments to streamline biopharmaceutical discovery and production.
Houdini Bio
Houdini Bio develops software that redesigns therapeutic DNA so the body does not attack it.
Nu Quantum
Nu Quantum builds distributed quantum computing infrastructure.
Nyobolt
Nyobolt builds ultra-fast charging energy technology for autonomous machines and high-demand industrial applications.
Paragraf
Paragraf manufactures scalable graphene-based electronic devices.
PharmEnable
PharmEnable develops next-generation small molecule drugs for challenging disease targets using an artificial intelligence platform.
Porotech
Porotech develops advanced gallium nitride semiconductor technology for micro-LED displays.
PredictImmune
PredictImmune develops prognostic tools for guiding treatment in immune-mediated diseases.
Psyomics
Psyomics develops artificial intelligence software to improve mental health assessment and diagnosis.
Qkine
Qkine manufactures specialist bioactive proteins for stem cell and regenerative medicine applications.
RegGenome
RegGenome turns complex regulatory information into machine-readable data using artificial intelligence.
Riverlane
Riverlane builds quantum error correction technology to remove hardware errors.
RoboK
RoboK develops computer vision technology that turns standard industrial CCTV into proactive workplace safety monitors.
Sano Genetics
Sano Genetics provides a comprehensive software platform for precision medicine clinical trials.
Semarion
Semarion develops microcarrier technology that turns adherent cells into assay-ready reagents.
Sorex Sensors
Sorex Sensors develops high-sensitivity MEMS mass sensors for industrial and consumer applications.
Trismik
Trismik builds adaptive evaluation infrastructure for artificial intelligence systems.
Wave Photonics
Wave Photonics develops on chip photonics designs for quantum technologies, sensors, and datacentre applications.
Where You At
Where You At provides offline location sharing and crowd management tools for venues and festivals.
Zetta Genomics
Zetta Genomics builds genomic data analysis platforms for precision medicine and healthcare.
auryx
Auryx turns the microphones inside everyday earbuds into continuous health monitors.
iKVA
iKVA provides an artificial intelligence platform to locate internal and external corporate knowledge.
xWatts
xWatts provides automated energy management and optimisation for complex estates.
Christine Martin
Head of Seed Funds
Christine brings investment and directorship experience across life science and venture organisations, including Cambridge Enterprise and SDS Therapeutics.
LinkedIn
James Thomas
Senior Investment Associate
James brings investment and advisory experience across university spin-outs and science-based start-ups, holding roles with Cambridge Enterprise, Martlet Capital, and Cambridge Angels. He currently serves as an operator in residence at Founders at the University of Cambridge and a non-executive director at BugBiome.
LinkedInElaine Loukes
Investment Director
Desmond Cheung
Senior Investment Analyst
Desmond brings deeptech investment and consulting experience from roles at Foresight Group, Cambridge Enterprise, and TTP.
LinkedIn
Chris Gibbs
Investment Director
Chris serves as an investment director at Cambridge Enterprise and holds several non-executive director roles. He brings deep tech and sustainability investment experience.
LinkedIn
Amanda Wooding
Deputy Head of Ventures
Amanda brings investment and life sciences experience from her roles at Cambridge Enterprise, Kalium Health, and PredictImmune.
LinkedInMarcio Siqueira
Head of Physical Sciences
Marcio brings commercialisation and leadership experience from Cambridge Enterprise, Imperial College London, and Oxford Instruments. He previously founded and led Almax easyLab.
LinkedInSCVC led the pre-seed round with backing from Deep Science Ventures and Cambridge Enterprise VC to help the startup expand its team and partnerships.
"Cellular machinery still rejects these therapies, limiting long-term effectiveness and forcing costly, unsafe doses. Our platform introduces a vital shift from trial-and-error screening to repeatable, engineering-driven DNA design,"
The Cambridge healthtech startup will use the capital to advance its acoustic monitoring technology and expand its team.
Parkwalk led the round to help the University of Cambridge spinout expand its manufacturing and commercial reach.
The London-based energy management platform raised the capital from Cambridge Enterprise Ventures, Cambridge Angels, Parkwalk, and R42 to scale its product development.
"Our mission is straightforward but ambitious: to decarbonise the world’s most complex real estate in a way that is intelligent, automated and scalable. We don’t just tell you what to do, we do it for you. This funding allows us to double down on the growth and product investment needed to compete at scale."
The funding comprises private equity and a state grant to expand research and development operations.
"Cambridge Photon Technology exemplifies the kind of transformative innovation needed to accelerate the global transition to sustainable energy and address climate challenges."
-20webclip.png)
